APLM
Price
$6.67
Change
+$0.17 (+2.62%)
Updated
Jun 6, 10:30 AM (EDT)
Capitalization
7.17M
KURA
Price
$6.73
Change
+$0.16 (+2.44%)
Updated
Jun 6 closing price
Capitalization
582.65M
54 days until earnings call
Interact to see
Advertisement

APLM vs KURA

Header iconAPLM vs KURA Comparison
Open Charts APLM vs KURABanner chart's image
Apollomics
Price$6.67
Change+$0.17 (+2.62%)
VolumeN/A
Capitalization7.17M
Kura Oncology
Price$6.73
Change+$0.16 (+2.44%)
Volume$767.85K
Capitalization582.65M
APLM vs KURA Comparison Chart
Loading...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLM vs. KURA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Buy and KURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (APLM: $6.50 vs. KURA: $6.73)
Brand notoriety: APLM and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 12% vs. KURA: 56%
Market capitalization -- APLM: $7.17M vs. KURA: $582.65M
APLM [@Biotechnology] is valued at $7.17M. KURA’s [@Biotechnology] market capitalization is $582.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • APLM’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both APLM and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 5 TA indicator(s) are bullish.

  • KURA’s TA Score: 5 bullish, 3 bearish.

Price Growth

APLM (@Biotechnology) experienced а +6.56% price change this week, while KURA (@Biotechnology) price change was +18.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

APLM is expected to report earnings on Apr 03, 2025.

KURA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($583M) has a higher market cap than APLM($7.17M). KURA YTD gains are higher at: -22.732 vs. APLM (-33.333). APLM has higher annual earnings (EBITDA): -56.38M vs. KURA (-177.18M). APLM has less debt than KURA: APLM (4.72M) vs KURA (19.4M). KURA has higher revenues than APLM: KURA (68M) vs APLM (0).
APLMKURAAPLM / KURA
Capitalization7.17M583M1%
EBITDA-56.38M-177.18M32%
Gain YTD-33.333-22.732147%
P/E RatioN/AN/A-
Revenue068M-
Total CashN/A658M-
Total Debt4.72M19.4M24%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KURA
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDHX23.880.07
+0.29%
Artisan Global Equity Advisor
EHSTX25.70N/A
N/A
Eaton Vance Large-Cap Value A
RYCMX35.97N/A
N/A
Rydex Russell 2000 1.5x Strategy C
PMYCX40.29N/A
N/A
Putnam Core Equity Fund C
FCENX13.64N/A
N/A
Franklin International Core Equity Adv

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with HCWB. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then HCWB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
N/A
HCWB - APLM
46%
Loosely correlated
+1.51%
RVMD - APLM
33%
Loosely correlated
+2.21%
PHAR - APLM
31%
Poorly correlated
+5.78%
ZIVO - APLM
28%
Poorly correlated
-1.71%
KURA - APLM
26%
Poorly correlated
+2.44%
More